We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The government’s effort to compare different drug products is moving forward, with the NIH’s National Eye Institute funding a clinical trial comparing two drugs used to treat advanced age-related macular degeneration (AMD), the leading cause of blindness among the elderly.